These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11121508)

  • 21. Retroviral bicistronic vectors.
    Pfützner W
    Drug News Perspect; 2008 Nov; 21(9):473-80. PubMed ID: 19180265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety features of retroviral vectors.
    Hansen AC; Pedersen FS
    Curr Opin Mol Ther; 2002 Aug; 4(4):324-33. PubMed ID: 12222870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reticuloendotheliosis viruses and derived vectors.
    Dornburg R
    Gene Ther; 1995 Jul; 2(5):301-10. PubMed ID: 7671105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting retrovirus entry.
    Cosset FL; Russell SJ
    Gene Ther; 1996 Nov; 3(11):946-56. PubMed ID: 8940634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviral vectors: new applications for an old tool.
    Barquinero J; Eixarch H; Pérez-Melgosa M
    Gene Ther; 2004 Oct; 11 Suppl 1():S3-9. PubMed ID: 15454951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
    Blesch A
    Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
    Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z
    Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting retroviral vector function and structural integrity.
    McLachlin JR; Mittereder N; Daucher MB; Kadan M; Eglitis MA
    Virology; 1993 Jul; 195(1):1-5. PubMed ID: 8391178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.
    Dupont F; Karim A; Dumon JC; Mine N; Avalosse B
    Gene Ther; 2001 Jun; 8(12):921-9. PubMed ID: 11426332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
    Werner M; Kraunus J; Baum C; Brocker T
    Gene Ther; 2004 Jun; 11(12):992-1000. PubMed ID: 15029232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction to viral vectors.
    Warnock JN; Daigre C; Al-Rubeai M
    Methods Mol Biol; 2011; 737():1-25. PubMed ID: 21590391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cell cycle status on early events in retroviral replication.
    Katz RA; Greger JG; Skalka AM
    J Cell Biochem; 2005 Apr; 94(5):880-9. PubMed ID: 15669021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [General principles of the production and use of retroviral vectors].
    Lehn P
    Pathol Biol (Paris); 1993 Oct; 41(8):658-62. PubMed ID: 8290308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
    Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
    J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroviral vector-mediated gene expression in hematopoietic cells.
    Baum C; Richters A; Ostertag W
    Curr Opin Mol Ther; 1999 Oct; 1(5):605-12. PubMed ID: 11249667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retroviral targeted delivery.
    Schnierle BS; Groner B
    Gene Ther; 1996 Dec; 3(12):1069-73. PubMed ID: 8986432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vectors and delivery systems in gene therapy.
    Gardlík R; Pálffy R; Hodosy J; Lukács J; Turna J; Celec P
    Med Sci Monit; 2005 Apr; 11(4):RA110-21. PubMed ID: 15795707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SV40-based gene therapy vectors: turning an adversary into a friend.
    Strayer DS
    Curr Opin Mol Ther; 2000 Oct; 2(5):570-8. PubMed ID: 11249759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral vectors: a wide range of choices and high levels of service.
    Osten P; Grinevich V; Cetin A
    Handb Exp Pharmacol; 2007; (178):177-202. PubMed ID: 17203656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.